Treatment Markets

Aethlon researchers have demonstrated that the Hemopurifier™ rapidly separates and captures infectious viruses and toxins from circulation in a manner similar to the natural immune response of clearing viruses and toxins before cell and organ infection. Supporting research reinforces that the viral diffusion principals combined with the broad-spectrum affinity of compounds immobilized within the Hemopurifier will allow the capture of many viruses and toxins associated with both chronic and acute infectious disease conditions. These include drug and vaccine resistant bioweapons, naturally evolving pandemic threats, and chronic infectious disease conditions such as Hepatitis-C (HCV) and the Human Immunodeficiency Virus (HIV).